Giant nonfunctioning adrenocortical carcinoma: a case report and review of the literature

Ahmad Almarzouq, Sami Asfar, Sundus Hussain, Adel Al-Hunayan, Saad Aldousari 1


 

Affiliations

31 October 2014

-

doi: 10.1186/1756-0500-7-769

Abstract

Background: Adrenocortical carcinoma is a rare and aggressive malignancy. Patients usually present early with manifestation of abnormal hormone secretion. However, adrenocortical carcinoma can also be nonfunctioning, and such patients present late with a mass effect or distant metastases.

Case presentation: We herein report a case of a 30-year-old Sri-Lankan woman who presented with a 3-month history of left flank pain associated with nausea, vomiting, and weight loss. Imaging revealed a large left upper quadrant mass with a 1.8-cm left lung nodule. The differential diagnoses included a left adrenal mass, left upper pole renal mass, and retroperitoneal sarcoma. A functional adrenal work-up revealed no abnormal findings. Surgical excision of the mass was uneventful with no postoperative complications. Pathological analysis revealed a nonfunctioning adrenocortical carcinoma measuring 16 × 14 × 10 cm. To our knowledge, a mass of this size is among the largest nonfunctioning adrenocortical carcinomas reported in the published literature. The investigations and approach to treatment were consistent with those in the published literature.

Conclusion: Large nonfunctioning adrenocortical carcinomas pose a diagnostic and therapeutic challenge, and most are diagnosed at a late stage. Appropriate imaging and functional work-up of the mass are vital before treatment. Surgical excision is safe, even for large adrenocortical carcinomas; excision in patients with advanced disease has been shown to have the best outcomes.

References

  1.  
    1. Norton JA. Adrenal tumors. In: DeVita VTJr, Hellman S, Rosenberg SA., editors. Cancer: Principles and Practice of Oncology. 7. Philadelphia, PA: Lippincott Williams Wilkins; 2005. pp. 1528–1539.
  2.  
    1. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C. Adrenocortical carcinomas: Surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg. 2001;25:891–897. doi: 10.1007/s00268-001-0047-y. - DOI - PubMed
  3.  
    1. Kopf D, Goretzki PE, Lehnert H. Clinical management of malignant adrenal tumors. J Canc Res Clin Oncol. 2001;127(3):143–155. doi: 10.1007/s004320000170. - DOI - PubMed
  4.  
    1. Gaujoux S, Al-Ahmadie H, Allen PJ, Gonen M, Shia J, Dángelica M, Dematteo R, Fong Y, Jamagin WR. Resection of adrenocortical carcinoma liver metastasis: is it justified? Ann Surg Oncol. 2012;19:2643. doi: 10.1245/s10434-012-2358-7. - DOI - PubMed
  5.  
    1. Kemp C, Ripley R, Mathur A, Steinburg SM, Nguyen DM, Fojo T, Schrump DS. Pulmonary Resection for Metastatic Adrenocortical Carcinoma: The National Cancer Institute Experience. Ann Thorac Surg. 2011;92(4):1195–1200. doi: 10.1016/j.athoracsur.2011.05.013. - DOI - PMC - PubMed
  6.  
    1. Vassilopoulou-Sellin R, Schultz PN. Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer. 2001;92:1113. doi: 10.1002/1097-0142(20010901)92:5<1113::AID-CNCR1428>3.0.CO;2-I. - DOI - PubMed
  7.  
    1. Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, Waguespack SG, Naing A, Sircar K, Wood CG, Pagliaro L, Jimenez C, Vassilopoulou-Sellin R, Hebra MA. Adrenocortical Carcinoma: Clinical Outcomes and prognosis of 330 Patients at a Tertiary Care Center. Eur J Endocrinol. 2013;169:891–899. doi: 10.1530/EJE-13-0519. - DOI - PMC - PubMed
  8.  
    1. Schulick RD, Brennan MF. Long-Term Survival After Complete Resection and Repeat Resection in Patients With Adrenocortical Carcinoma. Ann Surg Oncol. 1999;6:719–726. doi: 10.1007/s10434-999-0719-7. - DOI - PubMed
  9.  
    1. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer. 2005;12:667. doi: 10.1677/erc.1.01029. - DOI - PubMed
  10.  
    1. Norton J, Le H. Adrenal tumors. In: DeVita VT, editor. Cancer. 6. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 1770–1785.
  11.  
    1. Deandreis D, Leboulleux S, Caramella C, Schlumberger M, Baudin E. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma. Horm Cancer. 2011;2:354. doi: 10.1007/s12672-011-0091-5. - DOI - PubMed
  12.  
    1. Weiss LM. Comperative histologic study of 43 metastasizing and non metastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8:163–169. doi: 10.1097/00000478-198403000-00001. - DOI - PubMed
  13.  
    1. Tseng Y. Wu s, Chao, Wu C J, Chau T. International Journal of Nephrology: Yang S S. A Giant Non-Functional Adrenocortical Carcinoma Presenting With Acute Kidney Injury; 2013. - PubMed
  14.  
    1. Kapoor A, Morris T, Rebello R. Guidelines for the Management of the Incidentally Discovered Adrenal Mass. Can Urol Assoc J. 2011;5(4):241–247. doi: 10.5489/cuaj.11135. - DOI - PMC - PubMed
  15.  
    1. National Institutes of Health “NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”) NIH Consensus and State-of-the-Science Statements. 2002;19:1–25. - PubMed
  16.  
    1. Benassai G, Desiato V, Bianco T, Seviro L, Compagna R, Vigliotti G, Limite B, Quatro G. Adrenocortical carcinoma: What the surgeon needs to know. Case report and literature review. Int J Surg. 2014;12S1:S22–S28. doi: 10.1016/j.ijsu.2014.05.030. - DOI - PubMed

Page Navigation